Fusion Pharmaceuticals Inc. (FUSN) Misses Q1 EPS by 3c

Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) reported Q1 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Fusion Pharmaceuticals Inc. (FUSN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c